{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:23:45Z","timestamp":1790018625183,"version":"4.0.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002738","name":"Ville de Paris","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002738","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ile-de-France"},{"name":"Interministerial Mission for Combating Drugs and Addictive Behaviours of Seine-Saint-Denis","award":["MILDECA DDCS 93"],"award-info":[{"award-number":["MILDECA DDCS 93"]}]},{"name":"French Directorate-general for Health"}],"content-domain":{"domain":["ijdp.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.drugpo.2014.09.010","type":"journal-article","created":{"date-parts":[[2014,10,3]],"date-time":"2014-10-03T18:40:52Z","timestamp":1412361652000},"page":"412-419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Drug analysis of residual content of used syringes: A new approach for improving knowledge of injected drugs and drug user practices"],"prefix":"10.1016","volume":"26","author":[{"given":"Thomas","family":"N\u00e9fau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elo\u00efse","family":"Charpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Elyasmino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Duplessy-Garson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Karolak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1.","key":"10.1016\/j.drugpo.2014.09.010_bib0005","article-title":"Botulism in injecting drug users, Dublin, Ireland, November\u2013December 2008","volume":"14","author":"Barry","year":"2009","journal-title":"Euro Surveillance: Bulletin Europ\u00e9en Sur Les Maladies Transmissibles"},{"issue":"Suppl. 1","key":"10.1016\/j.drugpo.2014.09.010_bib0010","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1097\/00042560-199802001-00010","article-title":"Single-use needles and syringes for the prevention of HIV infection among injection drug users","volume":"18","author":"Des Jarlais","year":"1998","journal-title":"Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association"},{"issue":"4","key":"10.1016\/j.drugpo.2014.09.010_bib0015","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3201\/eid1204.050599","article-title":"Tetanus in injecting drug users, United Kingdom","volume":"12","author":"Hahn\u00e9","year":"2006","journal-title":"Emerging Infectious Diseases"},{"issue":"6","key":"10.1016\/j.drugpo.2014.09.010_bib0020","first-page":"503","article-title":"From margin to mainstream: The evolution of harm reduction responses to problem drug use in Europe","volume":"15","author":"Hedrich","year":"2008","journal-title":"Drugs: Education, Prevention, and Policy"},{"issue":"3","key":"10.1016\/j.drugpo.2014.09.010_bib0025","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0891-5520(02)00013-2","article-title":"Ocular manifestations of injection drug use","volume":"16","author":"Kim","year":"2002","journal-title":"Infectious Disease Clinics of North America"},{"issue":"1","key":"10.1016\/j.drugpo.2014.09.010_bib0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1477-7517-1-4","article-title":"Assessing and improving needle exchange programs: Gaps and problems in the literature","volume":"1","author":"Ksobiech","year":"2004","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.drugpo.2014.09.010_bib0035","series-title":"Preventing HIV infection among injecting drug users in high risk countries: An assessment of the evidence","author":"National Research Council","year":"2006"},{"issue":"9241","key":"10.1016\/j.drugpo.2014.09.010_bib0040","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/S0140-6736(00)03133-0","article-title":"Injectional anthrax in a heroin skin-popper","volume":"356","author":"Ringertz","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.drugpo.2014.09.010_bib0045","series-title":"World Drug Report. New York, NY","doi-asserted-by":"crossref","DOI":"10.18356\/d30739c2-en","author":"UNODC","year":"2013"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095539591400276X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095539591400276X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T17:22:29Z","timestamp":1538155349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095539591400276X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S095539591400276X"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2014.09.010","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug analysis of residual content of used syringes: A new approach for improving knowledge of injected drugs and drug user practices","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2014.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}